Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Trinity Biotech plc ADR (TRIB)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: TRIB
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Analysis - Latest Articles
Trinity Biotech: Irish Eyes Smiling at Microcap Value
James Levy
•
Sep 09
•
3 Comments
Extreme FDA Trades: 20 Stocks Under 5 Bucks
Mike Havrilla
•
Jul 21
•
3 Comments
FDA Calendar Updates: Spectrum, Labopharm, Human Genome Sciences, Orexigen, Trinity
Mike Havrilla
•
Jul 20
•
1 Comment
FDA Calendar Updates: King Pharma, Pain Therapeutics
Mike Havrilla
•
Jul 08
•
6 Comments
FDA Extreme Trades: 16 Stocks Under 5 Bucks
Mike Havrilla
•
Jun 28
•
10 Comments
FDA Calendar Updates: Trinity Biotech Awaiting Two Responses
Mike Havrilla
•
Jun 11
•
2 Comments
More articles on TRIB »
Latest Transcript
Trinity Biotech plc. Q2 2008 Earnings Call Transcript
Tue July 22, 2008
More transcripts on TRIB »
Instablogs
Trinity Biotech (TRIB) : When Irish Eyes are Smiling at Microcap Value
Wed September 9, 2009
•
James Levy
•
Comment!
FDA Calendar Updates: DDSS, HGSI, OREX, SPPI, TRIB
Mon July 20, 2009
•
Mike Havrilla
•
1 Comment
FDA Calendar Updates: KG, PTIE, DRRX, ALTH, TRIB, CBST, DYAX
Tue July 7, 2009
•
Mike Havrilla
•
Comment!
Write a post on TRIB
|
More Instablogs on TRIB »
Sentiment
What advice would you give to
TRIB?
123 characters left
What's your view of TRIB?
Make sure you include TRIB
140 characters left
|
Settings
thevoice@voicedup.com
: (
TRIB
) - Shares rose 6.5 percent to $4.75 after U.S. health regulators approved its blood-clot analyzer.
Tue, Jul 07, 2009
More StockTalks on TRIB »